At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
HIV and the Hepatitis B Vaccine
Many people who have HIV may not receive the hepatitis B vaccine, according to a new study.
A Shorter Treatment for Hepatitis C
The US Food and Drug Administration (FDA) has approved a new treatment for chronic hepatitis C virus infection.
New Hepatitis Rx Approved
The US Food and Drug Administration (FDA) has approved a new medication to treat hepatitis.
New Options for Children with Hep C
The US Food and Drug Administration (FDA) has approved two medications to treat children with hepatitis C.
New Hep B Treatment Gets Green Light
The US Food and Drug Administration has approved a new medication to treat hepatitis B.
FDA: Risk Tied to Some Antiviral Medications
The US Food and Drug Administration (FDA) has issued a warning about the potential for hepatitis B virus (HBV) reactivation with the use of certain antivirals.
A Four-in-One Hit to Hep C
The US Food and Drug Administration has approved a tablet that contains four medications in one tablet to treat hepatitis C.
New Hepatitis C Rx Approved
The US Food and Drug Administration (FDA) has approved a new hepatitis C medication.
FDA Expands Label for Daklinza
On February 5, 2016, FDA approved changes to the DAKLINZA(daclatasvir) label to expand the indication to include HCV genotype 1 infection and expand dosage recommendations to the following populations and to revise dosage recommendations for HCV genotype 3 subjects with compensated (Child-Pugh A) cirrhosis:
FDA OKs New Hep C Rx
The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.